Spokane's Gestalt Diagnostics lands $7.5M in funding to enhance its AI tools for digital pathology, aiming to improve cancer ...

A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage ...

A team of international researchers has developed the world’s first artificial intelligence (AI) model that can accurately ...

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with artificial ...

A new liquid biopsy approach developed by Johns Hopkins Kimmel Cancer Center investigators could revolutionize brain cancer ...

Detecting cancer from a single drop of blood sounds like science fiction—but AI is making it a reality. In this episode, we ...

Those scenarios are on the horizon, according to the head of the Cancer Research UK, Dr Catherine Elliott.

Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignancies ...

Spotlight Pathology, a Manchester-based MedTech company developing AI-powered pathology tools, has secured £425,000 from ...

If you ask AI about the future of cancer care, it replies that it will ‘make cancer care more precise, proactive and ...

Early cancer biomarkers found in urine can improve screening procedures for the all-too-common prostate cancer.

The true strength of multimodal AI lies in its ability to gather and interpret diverse data sources—whether imaging, genetic ...